Cantitate/Preț
Produs
Total produse
Vezi coșul
Multiregional Clinical Trials for Simultaneous Global New Drug Development de Joshua Chen

Multiregional Clinical Trials for Simultaneous Global New Drug Development: Chapman & Hall/CRC Biostatistics Series

Editat de Joshua Chen, Hui Quan
en Limba Engleză Paperback – 18 dec 2020
In a global clinical development strategy, multiregional clinical trials (MRCTs) are vital in the development of innovative medicines. Multiregional Clinical Trials for Simultaneous Global New Drug Development presents a comprehensive overview on the current status of conducting MRCTs in clinical development. International experts from academia, industry, and health organizations address various aspects of the important problems in global clinical development and MRCTs.




The book first provides a high-level introduction to the context, motivation, opportunities, and challenges in simultaneous global clinical development using MRCTs. It then focuses on the design, monitoring, and analysis/interpretation of MRCTs. The book concludes with an examination of the latest research topics from MRCT perspectives, such as special considerations by local health authorities, health economic evaluations, benefit-risk assessment, and medical devices.




Explaining how to design, conduct, and interpret MRCTs, this book will help biostatisticians working in the late-stage clinical development of medical products. It will also be useful for statisticians and clinicians in the biopharmaceutical industry, regulatory agencies, and medical research institutes.
Citește tot Restrânge

Din seria Chapman & Hall/CRC Biostatistics Series

  • Structural Equation Modeling for Health and Medicine
    Preț: 34289 lei
  • 9% Statistical Methods for Dynamic Disease Screening and Spatio-Temporal Disease Surveillance
    Preț: 64331 lei
  • 9% Bayesian Precision Medicine
    Preț: 64304 lei
  • Joint Models for Longitudinal and Time-to-Event Data: With Applications in R
    Preț: 34142 lei
  • Bayesian Analysis with R for Drug Development: Concepts, Algorithms, and Case Studies
    Preț: 31141 lei
  • Confidence Intervals for Discrete Data in Clinical Research
    Preț: 35903 lei
  • Interface between Regulation and Statistics in Drug Development
    Preț: 35448 lei
  • Bayesian Adaptive Methods for Clinical Trials
    Preț: 35065 lei
  • Applied Meta-Analysis with R and Stata
    Preț: 35663 lei
  • Real-World Evidence in a Patient-Centric Digital Era
    Preț: 34837 lei
  • Sample Size Calculations in Clinical Research
    Preț: 31141 lei
  • 9% Estimands, Estimators and Sensitivity Analysis in Clinical Trials
    Preț: 72920 lei
  • Single-Arm Phase II Survival Trial Design
    Preț: 35722 lei
  • 8% Statistical Thinking in Clinical Trials
    Preț: 37664 lei
  • Real-World Evidence in Drug Development and Evaluation
    Preț: 35477 lei
  • 9% Causal Inference in Pharmaceutical Statistics
    Preț: 64152 lei
  • 5% Hybrid Frequentist/Bayesian Power and Bayesian Power in Planning Clinical Trials
    Preț: 33101 lei
  • Cure Models: Methods, Applications, and Implementation
    Preț: 28880 lei
  • 5% Statistical Methods in Health Disparity Research
    Preț: 66962 lei
  • Bayesian Methods in Pharmaceutical Research
    Preț: 36200 lei
  • 9% Value of Information for Healthcare Decision-Making
    Preț: 73199 lei
  • 9% ROC Analysis for Classification and Prediction in Practice
    Preț: 64457 lei
  • Signal Detection for Medical Scientists: Likelihood Ratio Test-based Methodology
    Preț: 35663 lei
  • 9% Innovative Methods for Rare Disease Drug Development
    Preț: 83328 lei
  • Medical Risk Prediction Models: With Ties to Machine Learning
    Preț: 38662 lei
  • 9% Quantitative Methods for Precision Medicine: Pharmacogenomics in Action
    Preț: 60832 lei
  • 9% Controlled Epidemiological Studies
    Preț: 80131 lei
  • 9% Statistical Design, Monitoring, and Analysis of Clinical Trials: Principles and Methods
    Preț: 59430 lei
  • 9% Analysis of Incidence Rates
    Preț: 94038 lei
  • 18% Design and Analysis of Clinical Trials for Predictive Medicine
    Preț: 77513 lei
  • 18% Bayesian Methods in Health Economics
    Preț: 69228 lei
  • 18% Medical Biostatistics
    Preț: 169518 lei
  • 26% Dose Finding by the Continual Reassessment Method
    Preț: 87242 lei
  • 18% Design and Analysis of Bridging Studies
    Preț: 76971 lei
  • 26% Statistics In the Pharmaceutical Industry
    Preț: 82306 lei
  • 15% Fundamental Concepts for New Clinical Trialists
    Preț: 66442 lei
  • 25% Statistical Methods for Drug Safety
    Preț: 55585 lei
  • 26% Randomization, Masking, and Allocation Concealment
    Preț: 62389 lei
  • 18% Quantitative Methods for HIV/AIDS Research
    Preț: 77045 lei
  • 25% Design and Analysis of Bioavailability and Bioequivalence Studies
    Preț: 77686 lei
  • 26% Exposure-Response Modeling: Methods and Practical Implementation
    Preț: 62635 lei
  • 18% Modern Adaptive Randomized Clinical Trials: Statistical and Practical Aspects
    Preț: 110217 lei
  • 25% Handbook of Regression and Modeling: Applications for the Clinical and Pharmaceutical Industries
    Preț: 88479 lei
  • 25% Randomized Phase II Cancer Clinical Trials
    Preț: 52517 lei
  • 25% Applied Biclustering Methods for Big and High-Dimensional Data Using R
    Preț: 55949 lei

Preț: 31146 lei

Preț vechi: 35663 lei
-13% Nou

Puncte Express: 467
Preț estimativ în valută:
5961€ • 6254$ • 4945£

Carte tipărită la comandă

Livrare economică 29 ianuarie-12 februarie 25

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9780367737221
ISBN-10: 0367737221
Pagini: 375
Dimensiuni: 156 x 234 mm
Greutate: 0.45 kg
Ediția:1
Editura: CRC Press
Colecția Chapman and Hall/CRC
Seria Chapman & Hall/CRC Biostatistics Series

Cuprins

Simultaneous Global Development. Multiregional Clinical Trial: Design Considerations. Multiregional Clinical Trial: Data Monitoring Committee and Monitoring Regional Difference. Multiregional Clinical Trial: Analysis, Reporting, and Interpretation. Multiregional Clinical Trial: Latest Development and Trend. Index.

Notă biografică

Joshua Chen is the global head of biostatistics and programming at Sanofi Pasteur. He previously worked on clinical development of small molecules, biologics, and vaccines at Merck Research Laboratories. His experience spans many therapeutic areas with a major focus on human vaccines and antiviral drugs. He has extensive experience in the study, design, conducting, and reporting of international clinical trials from proof of concept through regulatory approvals and life cycle management. His primary research interest is clinical trial designs, including group sequential methods, adaptive designs, and multiregional clinical trials (MRCTs). Dr. Chen was a colead of the cross-industry MRCT Consistency Working Group under PhRMA (2008–2011) and the Society for Clinical Trials (2012–2014). He earned his PhD in statistics from the University of Wisconsin–Madison.


Hui Quan is an associate vice president and global head of the methodology group in the Biostatistics and Programming Department of Sanofi–Aventis. A fellow of the American Statistical Association, he has 24 years of pharmaceutical industry experience in many therapeutic areas ranging from early phase to phase IV studies. He has published 82 papers, including 59 statistical papers. His research interests include multivariate analysis, safety analysis, multiplicity adjustment, missing handling, adaptive design, integrated data analysis, modeling and simulation, benefit/risk assessment, and MRCTs. Dr. Quan was a colead of the MRCT Consistency Assessment Working Group under PhRMA (2008–2011) and the Society for Clinical Trials (2012–2014). He earned his PhD in statistics from Columbia University.

Recenzii

This book consolidates current state of knowledge regarding relevant topics on MRCTs (design, operation, and analysis/interpretation) into well-organized chapters. This book should serve as a useful source of information to anyone who plans to work or is working on MRCTs. There are many on-going challenges and we also hope it will stimulate further research in MRCTs.
~Nobushige Matsuoka, PhD and Norisuke Kawai, PhD, Pfizer Japan Inc.
" . . . Contributors to this book are among the best experts in their corresponding fields. . . Most chapters are short, with about 20 pages including references. This length of chapter makes the book easy to read and easy to follow. Concepts involving design, conduct, and analysis of MRCT are not simple, but this book successfully presents all of these topics—setting the stage and drilling down to a reasonable depth, without unnecessary detail. It also introduces many real world examples to help readers understand some of the difficult concepts. . .  Each chapter introduces a stand-alone, self-contained topic. Cross-referencing of chapters is rarely needed, but is provided where appropriate. I learned a lot from this book, especially that issues arising in MRCT are much more difficult than issues in multi-center trials, from which much of my experience with clinical trials comes."
~Naitee Ting, Boehringer Ingelheim Pharmaceuticals, Inc.
"The editors have collected chapters and sections contributed by many authors, with each addressing a different important problem in global clinical development and MRCTs. The contributions to individual topics from academia, industry, and health authorities around the globe, strengthen the documentation greatly . . .  I fully endorse the views of the editors that biostatisticians working in the area of randomized controlled trials in general, and MRCTs in particular, will find this book a useful reference."
~Sada Nand Dwivedi, International So

Descriere

This book presents a comprehensive overview on the current status of conducting MRCTs in clinical development. It first provides a high-level introduction to the context, motivation, opportunities, and challenges in simultaneous global clinical development using MRCTs. It then focuses on the design, monitoring, and analysis/interpretation of MRC